Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cue Biopharma Inc.

    NASDAQ: CUE · Real-Time Price · USD
    0.59
    -0.01 (-1.99%)
    At close: Jun 16, 2025, 3:59 PM
    0.59
    -0.88%
    After-hours: Jun 16, 2025, 05:16 PM EDT
    -1.99%
    Bid 0.56
    Market Cap 44.63M
    Revenue (ttm) 7.99M
    Net Income (ttm) -40.58M
    EPS (ttm) -0.64
    PE Ratio (ttm) -0.93
    Forward PE -1.4
    Analyst Buy
    Ask 0.69
    Volume 118,593
    Avg. Volume (20D) 163,968
    Open 0.60
    Previous Close 0.60
    Day's Range 0.57 - 0.63
    52-Week Range 0.45 - 1.99
    Beta 1.42

    About CUE

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CUE
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CUE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 months ago
    +5.35%
    Cue Biopharma shares are trading higher. Citizens ... Unlock content with Pro Subscription
    2 months ago
    -17.67%
    Cue Biopharma shares are trading lower. The company reported FY24 financial results.
    news image

    1 month ago · zacks.com

    Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates

    Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.25 per share a year ago.

    news image

    1 month ago · zacks.com

    Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know

    Cue Biopharma (CUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    2 months ago · seekingalpha.com

    Cue Biopharma, Inc. (CUE) Business Update Call (Transcript)

    Cue Biopharma, Inc. (NASDAQ:CUE ) Business Update Call April 15, 2025 4:30 PM ET Company Participants Eric Ribner - LifeSci Advisors Dan Passeri - Chief Executive Officer Lucinda Warren - Chief Busine...

    news image

    2 months ago · zacks.com

    Cue Biopharma, Inc. (CUE) Reports Q4 Loss, Misses Revenue Estimates

    Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.28 per share a year ago.

    Add to Watchlist